Neoadjuvant Chemotherapy in Nasopharyngeal Carcinoma

J. Sabeeh Al-Rawaq, Khudair

	Neoadjuvant Chemotherapy in Nasopharyngeal Carcinoma
Journal of the Faculty of Medicine
Article 1, Volume 54, Issue 1, 2012, Pages 7-9
Author
Khudair J. Sabeeh Al-Rawaq
Abstract
Back ground: nasopharyngeal carcinoma is rare in Iraq and the treatment of this tumor is usually by radiotherapy and chemotherapy. Objectives: this study was conducted to estimate the effect of neoadjuvant chemotherapy in Iraqi patients with nasopharyngeal carcinoma Patients and methods: This study included sixty patients already diagnosed with nasopharyngeal tumors who attended the department of oncology in Baghdad teaching hospital during the period from January 2009 to December 2010,50 patients of them were treated by using combination chemotherapy in the form of Paclitaxel,5Flurouracil and cisplatinol for 4 courses prior to radiotherapy. Neoadjuvant chemotherapy was given due to advanced stage at presentation and due to long waiting list for radiotherapy which takes at least 6 months.10 patients were excluded from the study due to different reasons. Results: About half of the patients had partial response to neoadjuvant chemotherapy,only 8 patients (16%) had complete response, 12 patients (24%) did not show any response and 5 patients (10%) have progressive disease during the course of neo adjuvant chemotherapy. Conclusion: Neoadjuvant chemotherapy is beneficial in the management of Nasopharyngeal Cancer regarding local control and overall response rate.
Keywords
Nasopharyngeal Carcinoma; radiotherapy; neoadjuvant chemotherapy; concomitant chemoradiation

Statistics Article View: 211 PDF Download: 73